Skip to main content
Premium Trial:

Request an Annual Quote

Investment Bank Upgrades Thermo Stock, Expects Strong Second Half of 05

NEW YORK, July 12 (GenomeWeb News) - An investment bank this morning upgraded shares of Thermo Electron stock, saying the company is positioned well for potentially positive financial results in the second half of the year.

 

Shares in the tool company inched up 1.47 percent, or $.40, to $27.70 in mid-afternoon trading on the news.

 

J.P. Morgan upgraded shares of Thermo Electron to "overweight" from "neutral" "citing improving macro trends in the life science and industrial markets and potentially positive second-quarter results," according to a Marketwatch report.

 

The company "also appears poised for a strong second-half 2005 and 2006, with a solid pipeline of new products and recent acquisitions for the process control and equipment maker," the report quoted a J.P. Morgan analysts as saying.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.